Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] - N0000193989
Pharmacologic Class Information
Pharmacologic Code | N0000193989 |
Pharmacologic Name | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
80446-401 | Kimmtrak | Non-Proprietary Name: Tebentafusp | Injection, Solution, Concentrate | Intravenous | Immunocore Commercial Llc | ACTIVE |